logo

For the Inventor, By the Inventor

Allschwil, Switzerland

Idorsia Pharmaceuticals Ltd


USPTO Granted Patents = 77



Trademarks = 14

Forward Citations = 135

Loading Chart...
Loading Chart...

113 inventors (with patents filed for the assignee):

goldMedal Christoph Boss (16 out of 59 patents)

silverMedal Martin Bolli (15 out of 66 patents)

bronzeMedal Markus Von Raumer (12 out of 15 patents)

4.  Bibia Heidmann (12 out of 21 patents)

5.  Thierry Sifferlen (12 out of 40 patents)

6.  John Gatfield (10 out of 13 patents)

7.  Christine Brotschi (9 out of 18 patents)

8.  Cornelia Zumbrunn (9 out of 13 patents)

9.  Sylvia Richard-Bildstein (8 out of 28 patents)

10.  Jodi T Williams (8 out of 17 patents)

11.  Julien Pothier (7 out of 11 patents)

12.  Markus Gude (7 out of 27 patents)

13.  Romain Siegrist (7 out of 15 patents)

14.  Corinna Grisostomi (7 out of 21 patents)

15.  Lubos Remen (7 out of 14 patents)


Core Competencies:
Pyridin Derivatives
PGE2 Receptor Modulators
4-Pyrimidinesulfamide Derivatives
C5A Receptor Modulators
Indole Derivatives
Galectin-3 Inhibitors
Vaccine Development
Calcium Channel Blockers
Antibacterial Compounds
Crystalline Forms
Thio-beta-D-Galactopyranoside Derivatives
Cyclopropyl Compounds

77 patents:

1. 12479820 - Pyridin-3-yl derivatives (2025-11-25),
2. 12410208 - (2-acetamidyl)thio-beta-D-galactopyranoside derivatives (2025-09-09),
3. 12404295 - (Hetero)aryl-methyl-thio-beta-D-galactopyranoside derivatives (2025-09-02),
4. 12344597 - Alkoxy-substituted pyridinyl derivatives as LPA1 receptor antagonists and their use in the treatment of fibrosis (2025-07-01),
5. 12319672 - Alpha-D-galactopyranoside derivatives (2025-06-03),
6. 12312362 - Spiro derivatives of Alpha-D-galactopyranosides (2025-05-27),
7. 12304902 - Hydroxyheterocycloalkane-carbamoyl derivatives (2025-05-20),
8. 12297189 - Crystalline forms of a 4-pyrimidinesulfamide derivative aprocitentan (2025-05-13),
9. 12291520 - Galectin-3 inhibiting 2-hydroxycycloalkane-1-carbamoyl derivatives (2025-05-06),
10. 12291519 - 2-hydroxycycloalkane-1-carbamoyl (2025-05-06),
11. 12187756 - Stable vaccine against (2025-01-07),
12. 12144811 - Combination of a 4-pyrimidinesulfamide derivative with an SGLT-2 inhibitor for the treatment of endothelin related diseases (2024-11-19),
13. 12043643 - Vaccine against klebsiella pneumoniae (2024-07-23),
14. 12011444 - N-substituted indole derivatives as PGE2 receptor modulators (2024-06-18),
15. 11891413 - Vaccine against (2024-02-06),
IDORSIA PHARMACEUTICALS LTD is a leading biopharmaceutical company focused on discovering, developing, and bringing innovative solutions to patients suffering from neurological, immunological, and psychiatric conditions. With a commitment to scientific excellence and patient-centric approaches, IDORSIA strives to address significant unmet medical needs and improve patients' quality of life. To learn more about IDORSIA and its groundbreaking advancements, please visit their website.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

...
77 Patents

#2 in Allschwil

#196 in Switzerland

#9,505 in the World

...
Allschwil, Switzerland

Idorsia Pharmaceuticals Ltd

Forward Citations = 135

113 inventors:

goldMedal Christoph Boss (16 out of 59 patents)

silverMedal Martin Bolli (15 out of 66 patents)

bronzeMedal Markus Von Raumer (12 out of 15 patents)

4.  Bibia Heidmann (12 out of 21 patents)

5.  Thierry Sifferlen (12 out of 40 patents)

Please report any incorrect information to support@idiyas.com
Loading…